Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - ropinirolum - retardtabletten - ropinirolum 4 mg ut ropiniroli hydrochloridum, ammonio methacrylatis copolymerum b, hypromellosum, natrii laurilsulfas, copovidonum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 110 0.81 mg, e 132, e 171, pro compresso obducto corresp. natrium 1.077 mg. - morbo di parkinson - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - ropinirolum - retardtabletten - ropinirolum 8 mg ut ropiniroli hydrochloridum, ammonio methacrylatis copolymerum b, hypromellosum, natrii laurilsulfas, copovidonum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 171, e 172 (rubrum), e 172 (nigrum), e 172 (flavum), pro compresso obducto corresp. natrium 2.153 mg. - morbo di parkinson - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - omeprazolum - capsule gastroresistenti - omeprazolum 10 mg, sacchari sphaerae corresp. saccharum 40.01 mg, povidonum k 30, natrii laurilsulfas, carboxymethylamylum natricum a, trinatrii phosphas dodecahydricus, hypromellosum, triethylis citras, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii hydroxidum, talcum, e 171, kapselhülle: aqua, gelatina, e 171, drucktinte: lacca, ethanolum anhydricum, alcohol isopropylicus, propylenglycolum, alcohol butylicus, ammonii hydroxidum, kalii hydroxidum, aqua purificata, e 172 (nigrum), pro capsula corresp. natrium 0.45 mg. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - omeprazolum - capsule gastroresistenti - omeprazolum 20 mg, sacchari sphaerae corresp. saccharum 80.02 mg, povidonum k 30, natrii laurilsulfas, carboxymethylamylum natricum a, trinatrii phosphas dodecahydricus, hypromellosum, triethylis citras, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii hydroxidum, talcum, e 171, kapselhülle: aqua, gelatina, e 171, drucktinte: lacca, ethanolum anhydricum, alcohol isopropylicus, propylenglycolum, alcohol butylicus, ammonii hydroxidum, kalii hydroxidum, aqua purificata, e 172 (nigrum), pro capsula corresp. natrium 1.51 mg. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - omeprazolum - capsule gastroresistenti - omeprazolum 40 mg, sacchari sphaerae corresp. saccharum 160.05 mg, povidonum k 30, natrii laurilsulfas, carboxymethylamylum natricum a, trinatrii phosphas dodecahydricus, hypromellosum, triethylis citras, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii hydroxidum, talcum, e 171, kapselhülle: aqua, gelatina, e 171, drucktinte: lacca, ethanolum anhydricum, alcohol isopropylicus, propylenglycolum, alcohol butylicus, ammonii hydroxidum, kalii hydroxidum, aqua purificata, e 172 (nigrum), pro capsula corresp. natrium 3.03 mg. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - lercanidipinum - lactab - lercanidipini hydrochloridum 10 mg corrisp. lercanidipinum 9,4 mg, lactosum monohydricum 30 mg, cellulosum microcristallinum, carboxymethylamylum natricum una è di 11,5 mg, povidonum k 30, magnesio stearas, hypromellosum, talco, macrogolum 6000, e 102 270 µg, e 171, e 172, excipiens pro compresso haze. - essenziale ipertonia - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - lercanidipinum - lactab - lercanidipini hydrochloridum 20 mg corrisp. lercanidipinum il 18,8 mg, lactosum monohydricum 60 mg, cellulosum microcristallinum, carboxymethylamylum natricum dal 23 mg, povidonum k 30, magnesio stearas, hypromellosum, talco, macrogolum 6000, e 129 711 µg, e 132, e 171, excipiens pro compresso haze. - essenziale ipertonia - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - buprenorphinum - cerotti transdermici - buprenorphinum 20 mg, oleylis oleas, povidonum k 90, acido laevulinicum, acrilati e il vinylis acetatis polymerisatum (vernetzt), poli(ethylenis terephthalas), acrilati e il vinylis acetatis polymerisatum (nicht vernetzt), trägermaterial: poly(ethylenis terephthalas), per la preparazione per il 25 cm2, con la liberazione di 35 µg/h. - analgesico - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - buprenorphinum - cerotti transdermici - buprenorphinum 30 mg, oleylis oleas, povidonum k 90, acido laevulinicum, acrilati e il vinylis acetatis polymerisatum (vernetzt), poli(ethylenis terephthalas), acrilati e il vinylis acetatis polymerisatum (nicht vernetzt), trägermaterial: poly(ethylenis terephthalas), per la preparazione per il 37.5 cm2, con la liberazione 52,5 mcg/h. - analgesico - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - buprenorphinum - cerotti transdermici - buprenorphinum 40 mg, oleylis oleas, povidonum k 90, acido laevulinicum, acrilati e il vinylis acetatis polymerisatum (vernetzt), poli(ethylenis terephthalas), acrilati e il vinylis acetatis polymerisatum (nicht vernetzt), trägermaterial: poly(ethylenis terephthalas), per la preparazione per il 50 cm2, con la liberazione di 70 µg/h. - analgesico - synthetika